HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease.
Overview
- Brain Disease and Big Data Research Institute, College of Life Sciences and Oceanography, Shenzhen University,Shenzhen, 518060 Guangdong China
- Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions,Shenzhen, 518055 China
- Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Ministry of Education of China and Hubei Province for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, 430030 China
- Department of Laboratory Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital,Shenzhen, 518035 China
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University,Shenzhen, 518055 China
Abstract
Background: Astrocytes undergo reactive transformations in response to pathological stimuli and play a critical role in neuronal loss associated with Alzheimer’s disease (AD). However, the intrinsic mechanisms through which astrocytes detect amyloid-β (Aβ) pathology and develop neurotoxic properties remain inadequately understood. The dysregulation of class IIa Histone deacetylases (HDACs) has been implicated in astrocyte dysfunction under pathological conditions. This study aims to elucidate the role of HDAC7 as an astrocytic mediator of Aβ that drives the formation of neurotoxic reactive astrocytes, and to propose HDAC7 as a potential therapeutic target for mitigating neuronal loss and cognitive deficits in AD.
Methods: We examined HDAC7 expression in APP/
Results: HDAC7 was selectively upregulated in plaque-adjacent astrocytes in APP/
Conclusions: HDAC7 acts as an intrinsic effector within astrocytes, responding to Aβ pathology and converting astrocytes into a neurotoxic state through direct interaction with IKK. Targeting HDAC7 presents a promising strategy for astrocyte-directed therapeutic interventions in Alzheimer’s disease.
Supplementary Information: The online version contains supplementary material available at https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:33421650, at figshare; found in DataCite
Data availability
All data generated during this study and supporting the present results are available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 6 keywords, 12 MeSH terms, 5 funders, 60 references.
Cite
This paper
Ye, J., Deng, Y., Zhang, B., Li, C., Guo, X., Yue, R., Wan, H., Hao, Y., & Xiao, S. (2026). HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease. Alzheimer's research & therapy, 18(1), 196. https://
BibTeX
@article{ye2026hdac7,
author = {Ye, Jinwang and Deng, Yunsong and Zhang, Bingge and Li, Chengjia and Guo, Xing and Yue, Ruizhu and Wan, Huali and Hao, Yue and Xiao, Shifeng},
title = {{HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease}},
journal = {Alzheimer's research \& therapy},
year = {2026},
month = jun,
volume = {18},
number = {1},
pages = {196},
publisher = {BMC},
issn = {1758-9193},
doi = {10.1186/
url = {https://
pmid = {42332767},
pmcid = {PMC13540850}
}
RIS
TY - JOUR
AU - Ye, Jinwang
AU - Deng, Yunsong
AU - Zhang, Bingge
AU - Li, Chengjia
AU - Guo, Xing
AU - Yue, Ruizhu
AU - Wan, Huali
AU - Hao, Yue
AU - Xiao, Shifeng
TI - HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease
T2 - Alzheimer's research & therapy
J2 - Alzheimers Res Ther
PY - 2026
DA - 2026/
VL - 18
IS - 1
SP - 196
SN - 1758-9193
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "HDAC7 acts as an astrocytic mediator of Aβ pathology that directly engages IKK to drive astrocyte neurotoxicity and neurodegeneration in Alzheimer's disease",
"container-title": "Alzheimer's research & therapy",
"author": [
{
"family": "Ye",
"given": "Jinwang"
},
{
"family": "Deng",
"given": "Yunsong"
},
{
"family": "Zhang",
"given": "Bingge"
},
{
"family": "Li",
"given": "Chengjia"
},
{
"family": "Guo",
"given": "Xing"
},
{
"family": "Yue",
"given": "Ruizhu"
},
{
"family": "Wan",
"given": "Huali"
},
{
"family": "Hao",
"given": "Yue"
},
{
"family": "Xiao",
"given": "Shifeng"
}
],
"container-title-short":
"volume": "18",
"issue": "1",
"page": "196",
"DOI": "10.1186/
"PMID": "42332767",
"PMCID": "PMC13540850",
"ISSN": "1758-9193",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13024-025-00796-2
- Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis.Journal: Molecular neurodegenerationIn common: Alzheimer's / dementia, mouse, cellular / molecular, 8 references, author Jinwang Ye
- [2] doi:10.1038/s41467-026-71826-w
- Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/
PS1dE9 Alzheimer's disease model. Journal: Nature communicationsIn common: Alzheimer's / dementia, mouse, cellular / molecular, 6 references - [3] doi:10.7554/elife.95577 [code]
- SRF-deficient astrocytes provide neuroprotection in mouse models of excitotoxicity and neurodegeneration.Journal: eLifeIn common: Alzheimer's / dementia, other condition, mouse, 1 other category, 6 references
- [4] doi:10.1073/pnas.2511093123
- REV-ERB-alpha and -beta coordinately regulate astrocyte reactivity and proteostatic function.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: mouse, cellular / molecular, 6 references
- [5] doi:10.1073/pnas.2303809120
- Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: Alzheimer's / dementia, mouse, cellular / molecular, 6 references
- [6] doi:10.1172/jci162253 [code]
- Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity.Journal: The Journal of clinical investigationIn common: mouse, 6 references
- [7] doi:10.1016/j.apsb.2025.07.012 [code]
- Astrocyte FGF7/
FGFR2 autocrine signaling mediates neuroinflammation and promotes MPTP-induced degeneration of dopaminergic neurons. Journal: Acta pharmaceutica Sinica. BIn common: mouse, cellular / molecular, 5 references - [8] doi:10.1016/j.celrep.2024.114637
- Autism-associated CHD8 controls reactive gliosis and neuroinflammation via remodeling chromatin in astrocytes.Journal: Cell reportsIn common: mouse, cellular / molecular, 5 references
- [9] doi:10.1126/sciadv.adp8504 [code]
- Astrocytic RNA editing regulates the host immune response to alpha-synuclein.Journal: Science advancesIn common: cellular / molecular, 5 references
- [10] doi:10.1016/j.isci.2025.113745 [code]
- Single-nucleus RNA sequencing reveals GABAergic vulnerability and reactive gliosis driven by loss of TDP-43.Journal: iScienceIn common: Alzheimer's / dementia, mouse, 5 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
